McDermott Advises Anaconda Pharma Shareholders on Sale to Biota Pharmaceuticals

Overview


Emmanuelle Trombe, Anthony Paronneau, Noëmie Fort, Antoine Vergnat, Christophe Jolk, Jilali Maazouz, Myrtille Lapuelle, Joel Rubinstein and Elliott Smith were the McDermott lawyers from the Firm’s Paris, New York and Washington DC offices who advised the shareholders of Anaconda Pharma on the sale of the company to Biota Pharmaceuticals. Anaconda Pharma is a life sciences company that develops treatments against human papillomavirus (HPV) infections. Read the full article